Early progression of follicular lymphoma: a view of the problem and personal experience-Reference-Cited by-同舟云学术

Early progression of follicular lymphoma: a view of the problem and personal experience

Published:2022-04-11 Issue:2 Volume:17 Page:14-22
ISSN:2413-4023
Container-title:Oncohematology
language:
Short-container-title:Onkogematologiâ

Author:

Vernyuk M. A.¹^ORCID,Chervontseva A. M.¹^ORCID,Cherkashina I. V.¹^ORCID,Gushchina E. E.¹^ORCID,Khayrullina L. S.¹^ORCID,Fedenko A. A.¹^ORCID

Affiliation:

1. P.A. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Center, Ministry of Health of Russia

Publisher

Publishing House ABV Press

Subject

Oncology,Hematology

Reference25 articles.

1. Shadman M., Li H., Rimsza L. et al. Continued excellent outcomes in previously untreated patients with follicular lymphoma after treatment with CHOP plus Rituximab or CHOP plus 131I-Tositumomab: long-term follow-up of Phase III Randomized Study SWOOGS0016. J Clin Oncol 2018;36(7):697–703. DOI:10.1200/JCO.2017.74.5083.

2. Tumyan G.S. Follicular lymphoma: current trends and my choice. Klinicheskaya onkogematologiya = Clinical Oncohematology 2013;6:20–33. (In Russ.).

3. Lipof J.J., Barr P.M. Early Progression of Follicular Lymphoma. Biology and Treatment. Hematol Oncol Clin N Am 2020;34(4):757–69. DOI:10.1016/j.hoc.2020.02.009.

4. Casulo C., Le-Rademacher J., Dixon J. et al. Validation of POD24 as a robust early clinical endpoint of poor survival in follicular lymphoma: results from the Follicular Lymphoma Analysis of Surrogacy Hypothesis (FLASH) investigation using individual data from 5,453 patients on 13 clinical trials. Blood 2017. DOI:10.1182/BLOOD.V130.SUPPL_1.412.412.

5. Casulo C., Byrtek M., Dawson K.L. et al. Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: an analysis from the National LymphoCare Study. J Clin Oncol 2015;33(23):2516–22. DOI:10.1200/JCO.2014.59.7534.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple drugs;Reactions Weekly;2023-07-22